Canada: A "Green Rush" For Debt Financing?

Canadian cannabis policy announcements over the past year have spurred investment in licensed cannabis producers and dealers ("Licensed Producers"), resulting in one of Canada's newest growth industries. Deloitte projects the potential size of a legal, recreational retail cannabis market at $9 billion.2 Equity investors have responded with what is becoming known as the "green rush," with medical marijuana companies raising more than $466 million in Canadian capital markets in 2016.3

While it is high times for equity financing, there is far less buzz for debt financing of Licensed Producers. Indeed, the Chief Executive Officer of one leading Toronto Stock Exchange-listed Licensed Producer has gone on record to say that "debt financing is the principal absent business instrument for the [regulated cannabis] sector."4

What is holding lenders back from a "green rush" of debt financing?

Setting aside potential reputational risk associated with cannabis, there are other risks involved with lending to Licensed Producers:

  • Risks of Lending to Non-Compliant Borrowers: Since cannabis is currently a controlled substance,5 a borrower's non-compliance with the Access to Cannabis for Medical Purposes Regulations6 could create major risks for a lender. Under the Regulations, in order for a Licensed Producer to be legally permitted to cultivate, produce and/or sell marijuana, it must have received the requisite licence(s) from Health Canada. Noncompliance with such regulations can result in the revocation of a licence and has the potential to attract criminal liability/charges for the Licensed Producer. Actual or suspected non-compliance could therefore lead to a Licensed Producer's assets being forfeited to the Crown under civil forfeiture legislation;7 potentially resulting in a significant loss of a lender's collateral.
  • Difficulties Ascertaining Compliance: Production, shipping, packaging, record-keeping, client eligibility, product security and export of marijuana are all extensively regulated on an ongoing basis by Health Canada under complex rules. Lenders should carefully scrutinize the business operations and practices of a potential Licenced Producer. If credit facilities are provided, the lender should ensure that the borrower provides the appropriate monitoring compliance certificates (perhaps on a more frequent basis than in other industries) and that the lender is immediately provided with full details of any Health Canada concerns with respect to the borrower.
  • Inability to Collateralize Licences: In some industries where licences are scarce (as is currently the case in the cannabis industry), licences are often a borrower's most valuable asset. However, only transferable and relatively stable licences are useful collateral. Currently there is no statutory or policy guidance on the transferability of Health Canada issued marijuana licences. Whether or not a Health Canada issued licence can be safely collateralized is an issue that lenders should be mindful of, as there is ministerial discretion to suspend such licences without notice8 and it is not clear whether such licences constitute "property" over which a valid security interest can attach.9
  • Difficult Inventory Enforcement: When the inventory is cannabis, lenders are in the sticky situation of having a security interest in collateral that they are not legally permitted to possess or resell. Only a Licenced Producer is permitted to possess and resell cannabis and, in order to do so, the "senior person in charge," "responsible persons in charge" and other persons must themselves hold valid security clearances and authorizations from Health Canada in connection with the licence. As such, if a lender seeks to enforce and the borrower's employees with security clearances leave the business, successful liquidation would be jeopardized. A receiver would need to retain persons with the appropriate clearances, such as another Licensed Producer or perhaps certain of their staff, in order to deal with the regulated collateral.
  • Court Involvement: In a security realization scenario involving cannabis collateral, it is unlikely that Health Canada would take a passive role. To add credibility and certainty to a security enforcement situation involving cannabis collateral, a court-ordered receivership would be the most prudent course of action. A draft receivership order would likely have to be tailored to the requirements of the regulatory context, and Health Canada should be served with materials. This approach could potentially reduce the likelihood of suspension or cancellation of the Licenced Producer's Health Canada issued licence, legitimize the sale of cannabis inventory and increase the chances of recovery.
  • Few "White Knights": Although the Regulations permit resale to other Licenced Producers, the current scarcity of Licenced Producers means the number of potential purchasers is limited. Similarly, the equipment used by a Licenced Producer cultivating cannabis may be of limited value from a margining perspective, since the number of potential purchasers of this specialized collateral is low.

In light of these issues, how can lenders protect themselves? In addition to very careful pre-commitment diligence, lenders could increase their confidence by negotiating the following rights:

  1. conservative margining (particularly with respect to valuing intangibles and inventory collateral; Licenced Producers with valuable real property interests or transferable equipment would, of course, inspire greater lender confidence);
  2. periodic monitoring rights;
  3. periodic compliance reporting by the borrower;
  4. borrower to immediately provide notice to the lender of any Health Canada concern of compliance issues;
  5. borrower covenants mirroring the demands of the Regulations; and
  6. side agreements with one or more "senior person in charge," "responsible persons in charge" and other persons that hold a valid security clearance authorized and approved by Health Canada in connection with Health Canada issued licences that provide that persons will assist with and facilitate the enforcement of the lender's security in the event of a security realization scenario.10

In addition, an acknowledgment and consent from Health Canada regarding the lender's security could be requested, providing that Health Canada will cooperate with any courtappointed officer in the context of enforcement by the lender of its security, to facilitate realization or a sale to a Health Canada-approved purchaser. This process would be familiar for lenders operating in other regulated industries, such as mining or long-term care. Alternatively, a borrower could consider issuing a notice to Health Canada advising that the borrower has granted a security interest over its personal property, including cannabis inventory, to the lender, thereby putting Health Canada on notice of the lender's security interest.

In light of these challenges, it is not surprising that institutional debt capital has been largely absent from the early days of the Canadian "green rush." As policymakers contemplate future legislation, they should consider how to address the issues identified above and support the ability of secured lenders to realize on their security.

We encourage policymakers and commentators to think of debt capital as a necessary pillar of a responsible and safe cannabis legalization strategy. Property, plant and equipment improvements – the traditional domain of asset-based lending – are essential to establishing safe and compliant production and distribution facilities. Regulatory reform that stimulates debt financing could both blaze a trail for economic growth and close the trust gap for this budding industry.


1 A Student-at-law. The authors acknowledge the contributions of Andrew Biderman, Aaron Collins, Daniel Everall, Lorway Gosse, Donald Johnston, Jeremy Nemers and Kyle Plunkett to the various scenarios contemplated in this article.

2 A 2016 Deloitte study suggests that the Canadian retail market for regulated recreational marijuana product is between $4.9 billion and $8.7 billion, with potential upside (including spinoff effects) exceeding $22 billion. Available online at .

3 Sunny Freeman, "Why smaller banks take bigger slice of the growing medical marijuana business," Financial Post, online: January 30 2017,

4 Bruce Linton, CEO of Canopy Growth Corporation, quoted in Eric Lam, "This Canadian Marijuana Grower is Looking for a Loan," Bloomberg, online: July 29, 2016, https:// . Linton went on to comment: "if I was producing tomatoes that yielded this margin in these buildings, I'd have a lineup of debt instruments available."

5 Controlled Drugs and Substances Act, SC 1996, c 19.

6 SOR/2016-230 (the "Regulations").

7 In Ontario, the applicable legislation is the Civil Remedies Act, 2001, S.O. 2001, c. 28. Several other provinces have comparable statutes.

8 The Regulations provide wide discretion to the Health Canada to cancel permits on public safety or other grounds (s. 40(1), and provide that licences must be cancelled if the security clearances of any "responsible person in charge" lapse.

9 In several jurisdictions, non-transferable licences are defined in the relevant personal property security legislation as property over which a security interest can be taken. In others, including Ontario, this question is resolved on a notoriously uncertain common-law test, where analysis can sometimes ends up in the weeds: see Saulnier v. Royal Bank of Canada, 2008 SCC 58.

10 The consideration and structuring of such agreements would need to be considered.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Timothy Jones
In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions